J&J Gets FDA Approval Of Potentially Addictive Opioid Nucynta



Related Posts

Share This

Johnson & Johnson has attained approval for their long standing opioid Nucynta in extended release format by the U.S. Food and Drug Administration. Nucynta has a high potential for abuse, and users may become psychologically or physically dependent on the drug so this approval is somewhat controversial… Article

Related articles